For example, researchers at the State University of New York (SUNY), Upstate Medical University in Syracuse published data in the June issue of the journal Pharmacology concluding that the administration of the plant cannabinoids delta-8-THC and delta-9-THC halted cellular respiration and tumor growth in human oral cancer cells. Specifically, investigators reported that cannabinoids were a “potent inhibitor” of Tu183 human cancer cells, a notoriously difficult to treat type of oral cancer.

Of course, this is hardly the first time that pot’s compounds have been demonstrated to possess anti-cancer properties. As has been widely reported here and elsewhere, US government researchers were first aware of this finding over 35 years ago, and today there exist published scientific studies demonstrating that cannabinoids can inhibit the proliferation of a wide range of cancers — including brain cancer, prostate cancer, breast cancer, lung cancer, skin cancer, pancreatic cancer, biliary tract cancer, and lymphoma. Nonetheless, abstract prohibitionist concerns regarding marijuana’s supposed cancer risk continue to dominate the headlines while actual scientific studies debunking these allegations tend to go unnoticed.

Similarly, preclinical data published online last week in the journal Cell Communication and Signaling reported that the administration of the non-psychoactive cannabinoid cannabidiol (CBD) increases adult neurogenesis (the active production of new neurons) in laboratory animals. Authors speculated that cannabis’ pro-neurogenic effects may explain why the plant appears to be useful in the treatment of certain neurodegenerative disorders like Alzheimer’s disease or ALS.

As I wrote last week, to date there are now over 20,000 published studies or reviews in the scientific literature pertaining to marijuana and its active compounds — making marijuana the most studied plant on Earth. But what’s the point in further research if nobody even bothers to pay attention to the research that’s already been done?

Such is the case with a pair of just-published studies slated to appear in the journal Schizophrenia Research. The first study, conducted by a team of researchers at various New York state hospitals, the Yale University School of Medicine, and the National Institutes of Mental Health assessed whether there exists a causal association between cannabis use and the age of onset of psychosis in patients hospitalized for the first time for an episode of schizophrenia.

Despite previous media claims to the contrary, researchers concluded:
“Although the onset of cannabis use disorder preceded the onset of illness in most patients, our findings suggest that age at onset of psychosis was not associated with cannabis use disorders. Previous studies implicating cannabis use disorders in schizophrenia may need to more comprehensively assess the relationship between cannabis use disorders and schizophrenia, and take into account the additional variables that we found associated with cannabis use disorders.”

A separate study slated for publication in the same journal assessed the cognitive skills of schizophrenic patients with a history of cannabis use compared to non-users. Authors reported that patients with a history of marijuana use “demonstrated significantly better performance on measures of processing speed, verbal fluency, and verbal learning and memory” compared to abstainers. Marijuana use was also associated with better overall GAF (Global Assessment of Functioning) scores compared to those of non-users.

Authors concluded: “The results of the present analysis suggest that (cannabis use) in patients with SZ (schizophrenia) is associated with better performance on measures of processing speed and verbal skills. These data are consistent with prior reports indicating that SZ patients with a history of CUD (cannabis use disorders) have less severe cognitive deficits than SZ patients without comorbid CUD. … The present findings also suggest that CUD in patients with SZ may not differentially affect the severity of illness as measured by clinical symptomatology.”

Both study’s findings are in line with previous (though virtually unreported) research indicating that marijuana is unlikely to instigate incidences of schizophrenia in the general population, that cannabis use among patients with the disease is associated with higher cognitive function, and that at least some schizophrenics find subjective relief from symptoms of the illness by using pot. Nonetheless, odds are the nobody from the mainstream media will be champing at the bit to report on them.

Bottom line: marijuana’s complex relationship with schizophrenia is far from understood, and likely won’t be for some time. But that doesn’t give the MSM a free pass to only promote one side of the story.

Dear NORML Supporter:

It is not often that I feel compelled to write to NORML’s membership and supporters regarding the day-to-day operations of America’s leading marijuana lobby group. Then again, in my tenure as Executive Director of NORML and the NORML Foundation, there’s never been a time like right now.

Over the past several months NORML’s public prominence and political influence has grown by leaps and bounds. As I write you today I’m reflecting upon two of the most significant – and productive – weeks in NORML history.  As we close the year 2009 I am proud to say that NORML has galvanized its position as the leading marijuana law reform organization. Why do I say this?  Take a look at the events of these two weeks late this fall, and decide for yourself:

• Marijuana legalization in Massachusetts? NORML testifies ‘Yes!’
  On Wednesday, October 14, NORML’s Legal Counsel Keith Stroup and NORML Advisory Board Member Dr. Lester Grinspoon testified before the Massachusetts Joint Committee on Revenue in favor of House Bill 2929, ‘An Act to Regulate and Tax the Cannabis Industry.’ Members of NORML’s state affiliate, MassCann, also spoke on behalf of the measure, which was drafted by former NORML Board Member Richard Evans. The well-attended legislative hearing marked the first time that Massachusetts state legislators had ever publicly discussed legalizing marijuana, and the debate earned prominent media coverage throughout the state. 

• California Governor Arnold Schwarzenegger requests marijuana legalization debate
  In May Gov. Arnold Schwarzenegger publicly called for a debate on the merits of marijuana regulation. This October NORML Deputy Director Paul Armentano and CalNORML Coordinator Dale Gieringer obliged the Governor’s request, and provided his office with a comprehensive action plan for regulating marijuana production and distribution in California.

• Obama to Justice Department: Back off on medi-pot prosecutions
  On Monday, October 19, U.S. Deputy Attorney General David Ogden issued a historic memorandum to federal prosecutors advising them to no longer "focus federal resources … [on those] whose actions are in … compliance with existing state laws providing for the medical use of marijuana." The directive upheld a campaign promise by President Obama, who had pledged that he would not use "Justice Department resources to try to circumvent state laws." Ever since the President took office NORML and other drug policy reform groups had lobbied the administration to follow through, in writing, with this sensible policy. Tellingly, the administration’s decision was hailed by the mainstream media as a major step toward the enactment of marijuana liberalization in America. Not surprisingly, NORML representatives spent the days immediately following the administration’s announcement speaking with dozens of mainstream media outlets, including CNN, MSNBC, The Associated Press, and The Christian Science Monitor, urging Congress to move expeditiously to make the administration’s policy changes into permanent law.

• Mainstream media just can’t get enough pot
  Over the past month NORML has fielded multiple requests from producers at mainstream media, radio, and television outlets throughout the nation and the world. Notably, NORML’s staff participated in the production of Fox Business News weeklong series on the cannabis industry (air date October 19-23), Newsweek‘s five-part series on present and past marijuana policy (published October 16), and the October 14 edition of PBS’ News Hour with Jim Leher.  NORML has also recently received prominent coverage in periodicals such as the BBC, The Wall Street Journal, and Fortune Magazine. Unlike in past years – or even past months – the overall tone of all of these high profile features was favorable to marijuana law reform.  The underlying media message: marijuana is a commodity, not a moral threat, and it’s about time for America’s laws to start treating it that way.

• The Drug Czar’s office comes calling
  On Monday, October 24 – at the request of the White House – I participated in a strategic conference call with Drug Czar Gil Kerlikowske to discuss the drafting of the administration’s 2010 National Drug Control Strategy. You read that right: the Office of National Drug Control Policy reached out to NORML and requested NORML’s participation in crafting the administration’s future drug reform strategies. Yes, the same office that just one year ago inflicted the cannabis community with John Walters is now making house calls to NORML.

  My friends, the times are most definitely changing.

• NORML testifies at California Assembly hearings on legalization
  Finally, to conclude two of my busiest weeks ever as NORML and NORML Foundation Director, on Wednesday, October 28, NORML’s Paul Armentano and Dale Gieringer traveled to Sacramento to testify before the California Assembly on Public Safety to urge legislators to stop arresting responsible marijuana smokers.  "The criminal prohibition of marijuana has not dissuaded anyone from using marijuana or reduced its availability; however, the strict enforcement of this policy has adversely impacted the lives and careers of millions of people who simply elected to use a substance to relax that is objectively safer than alcohol," Armentano told the Committee. "NORML believes that the state of California ought to amend criminal prohibition and replace it with a system of legalization, taxation, regulation, and education." Like in Massachusetts two weeks earlier, the day-long hearing and was the first of its kind to take place before the California legislature.

So there you have it: two weeks in the life of NORML and the NORML Foundation.  Thank you for being there for us – so we can be there for you.

As we conclude this momentous year I rest assured knowing that with your continued financial contributions, NORML and the NORML Foundation will be able to maintain its position as the most trusted and respected marijuana law reform organizations in the United States.  That remains our commitment to you – the cannabis consumer – as we look ahead to the success and victories that await us in 2010.

With your generous support, we are ending marijuana prohibition. With your continued generous support, we’ll end marijuana prohibition once and for all.

Cannabem liberemus,

Allen St. Pierre
Executive Director

P.S. Please make your tax-deductible donation to the NORML Foundation in support of our national outreach and educational programs.

If you’d rather your donation be employed for state and federal lobbying purposes, please make sure that the donation is directed to ‘NORML‘, where donations are not tax deductible.

P.P.S. Donate $50 or more to either NORML Foundation (or NORML) and receive a copy of the new book ‘Marijuana is Safer, so why are we driving people to drink?‘ co-authored by NORML deputy director Paul Armentano.

For anyone who missed the worldwide corporate media’s hysterical anti-pot headlines last week, here’s a sampling:

Cannabis more damaging to adolescent brains than previously known
via Emax Health
“New research shows that teens who consume cannabis daily can suffer anxiety and depression. Smoking marijuana can have long-term irreversible effects on adolescent brains, and is more harmful to teens than previously known.”

Teen marijuana use affects brain permanently: study
via CBC News
“The findings suggest daily marijuana use by teens can cause depression and anxiety, and have an irreversible effect on the brain.”

Pot damage on teens worse than thought
via UPI wire services
“Daily consumption of marijuana in teens can cause depression and anxiety, and have irreversible long-term effect on the brain, Canadian researchers say.”

Cannabis brain damage worse in teens than thought: study
via The Canadian Press
“The effects of daily cannabis use on teenage brains is worse than originally thought, and the long-term effects appear to be irreversible, new research from McGill University suggests.”

Sounds scary, huh? It’s meant to. Only there’s three serious problems with the mainstream media’s alarmist coverage.

1) No adolescents — or for that matter, any human beings whatsoever — actually participated in the study.

2) No actual cannabis was consumed in the study.

3) No permanent brain damage was reported in the study.

Don’t believe me? Well then, check out the actual source of the headlines yourself.

Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission
via PubMed

“We tested this hypothesis by administering the CB(1) receptor agonist WIN55,212-2, once daily for 20 days to adolescent and adult rats. … Chronic adolescent exposure but not adult exposure to low (0.2 mg/kg) and high (1.0 mg/kg) doses led to depression-like behaviour in the forced swim and sucrose preference test, while the high dose also induced anxiety-like consequences in the novelty-suppressed feeding test. … These (findings) suggest that long-term exposure to cannabinoids during adolescence induces anxiety-like and depression-like behaviours in adulthood and that this may be instigated by serotonergic hypoactivity and noradrenergic hyperactivity.”

To summarize: Investigators administered daily doses of a highly potent synthetic cannabinoid receptor agonist WIN,55,212-2 to both adolescent rats and adult rats for 20 days. Days following their exposure, researchers documented altered serotonin production in younger rats. (Why investigators presumed that the change in serotonin production would be permanent I have no idea. After the initial 20-day waiting period, researchers do not appear to have tested the rats’ serotonin levels ever again.) Researchers also documented supposed depression-like and anxiety-like behavior in certain rats, based on various elaborate animal models and preference tests.

Yet somehow based on this speculative preclinical evidence, the mainstream media — in unison — proclaimed:

Reefer badness
via San Diego Tribune

“A study of Canadian teenagers … found that smoking the illicit drug is harder on young brains than originally thought. Writing in the journal Neurobiology of Disease, researchers at McGill University in Montreal said daily consumption of cannabis in teens can cause significant depression and anxiety and have an irreversible long-term effect on the brain.”

In truth, the purported ‘study’ never said anything of the sort!

So why the does the MSM consistently get the story wrong when it comes to pot? You can check out my previous thoughts on the issue here.

Apparently my latest missive has hit a nerve — as it has quickly risen to become the most read story on Alternet.

5 Things the Corporate Media Don’t Want You to Know About Cannabis
via Alternet.org

1. Marijuana Use Is Not Associated With a Rise in Incidences of Schizophrenia

2. Marijuana Smoke Doesn’t Damage the Lungs Like Tobacco

3. Cannabis Use Potentially Protects, Rather Than Harms, the Brain

4. Marijuana Is a Terminus, Not a ‘Gateway,’ to Hard Drug Use

5. Government’s Anti-Pot Ads Encourage, Rather Than Discourage, Marijuana Use

Read the full text of the story here.

Earlier today Reuters News Wire finally took the time to report that lifetime marijuana use is associated with a reduced risk of head and neck cancer. That’s according to the findings of a population-based case control study of some 1,000 subjects, published in the journal Cancer Prevention Research.

But you already know this because NORML initially posted the news in July.

To review, here is what the study found:

Authors reported, “After adjusting for potential confounders (including smoking and alcohol drinking), 10 to 20 years of marijuana use was associated with a significantly reduced risk of head and neck squamous cell carcinoma … [as was] moderate weekly use.”

Subjects who smoked marijuana and consumed alcohol and tobacco (two known high risk factors for head and neck cancers) also experienced a reduced risk of cancer, the study found.

“This association was consistent across different measures of marijuana use (marijuana use status, duration, and frequency of use). … Further, we observed that marijuana use modified the interaction between alcohol and cigarette smoking, resulting in a decreased HNSCC risk among moderate smokers and light drinkers, and attenuated risk among the heaviest smokers and drinkers.“

Notably, Reuters‘ writers took a much more skeptical view of the study’s findings, as evident by the headline:

Could smoking pot cut risk of head, neck cancer?
via Reuters Health

Strange that Reuters would frame their headline in the form of a question. After all, the study’s authors expressed no such reservations, concluding in the final line of their abstract, “Our study suggests that moderate marijuana use is associated with reduced risk of HNSCC (head and neck cancer).”

Reuters skepticism continues:

It’s unclear why marijuana would prevent cancer, if in fact the study is borne out by others, but the authors note that chemicals in pot called cannabinoids have been shown to have potential antitumor effects. Other studies have linked marijuana use to a reduced risk of some cancers, such as cancer of the prostate, and now head and neck cancer.

… Overall, however, research on the effects of marijuana on human health is mixed. Some studies have suggested the drug can increase a person’s risk of heart attack or stroke and cause some cancers such as lung cancer.

Let’s take things one at a time, shall we. First, it’s hardly ‘unclear’ as to why marijuana would be cancer-preventive. To quote the scientific journal Nature Reviews Cancer from 2003:

Cannabinoids: potential anticancer agents
via Nature Reviews Cancer

Cannabinoids inhibit tumor growth in laboratory animals. They do so by modulating key cell-signaling pathways, thereby inducing direct growth arrest and death of tumor cells, as well as by inhibiting tumor angiogenesis and metastasis. Cannabinoids are selective anti-tumor compounds, as they can kill tumor cells without affecting their non-transformed counterparts.

Reuters unnamed author(s) further add the caveat: “if in fact the study is borne out by others.” News flash: this study was performed precisely because pot’s cancer preventive effects had been “borne out in others,” such as this:

Study finds no cancer-marijuana connection
via The Washington Post

The largest study of its kind has unexpectedly concluded that smoking marijuana, even regularly and heavily, does not lead to lung cancer. … “We hypothesized that there would be a positive association between marijuana use and lung cancer, and that the association would be more positive with heavier use,” he said. “What we found instead was no association at all, and even a suggestion of some protective effect.”

Reuters further states: “Other studies have linked marijuana use to a reduced risk of some cancers, such as cancer of the prostate, and now head and neck cancer.” Notably, the wire service failed to include that cannabinoids also have documented anti-cancer fighting abilities in the treatment of: brain cancer, breast cancer, lung cancer, skin cancer, and pancreatic cancer — just to name a few.

And finally, Reuters obligatorily adds that pot’s effects on health are ‘mixed,’ alleging that “some studies have suggested the drug can increase a person’s risk of heart attack or stroke and cause some cancers such as lung cancer.” Ah yes, the ever elusive “some studies.”

Well, as for cannabis smoking and lung cancer, that claim was rebutted by the largest study of its kind, profiled above. As for the alleged risk of “heart attack or stroke,” a large-scale population study by Kaiser Permanente reported “no association of marijuana use with cardiovascular disease hospitalization or mortality.”

That said, I’m all for the media espousing skepticism regarding claims about cannabis. Of course, were the MSM to apply this same attitude to the federal government’s claims about marijuana and pot prohibition, we wouldn’t have to suffer through stories like these, now would we?

Effects of cannabis on lung function: a population-based cohort study
via nih.gov

The effects of cannabis on lung function remain unclear and may be different to tobacco. We compared the associations between use of these substances and lung function in a population-based cohort (n=1037). … Cumulative cannabis use was associated with higher forced vital capacity, total lung capacity, functional residual capacity, and residual volume. Cannabis was also associated with higher airways resistance but not with forced expiratory volume in 1 second, forced expiratory ratio, or transfer factor. These findings were similar amongst those who did not smoke tobacco.

By contrast, tobacco use was associated with lower forced expiratory volume in 1 second, lower forced expiratory ratio, lower transfer factor, and higher static lung volumes, but not with airways resistance. Cannabis appears to have different effects on lung function to those of tobacco.

Just in case you think that this is the first time that researchers have failed to document a decline in lung function in marijuana users, well, think again. And again. And again.

If Pot Prevented Cancer You Would Have Read About It, Right?
via TheHill.com

Two just published studies assessing adults’ risk of cancer have reported wildly divergent, and fairly extraordinary, outcomes. One study you may have read about. The other has been ignored entirely by the mainstream media.

… First, the study you may have heard of. Writing August 3 in the journal Cancer Epidemiology, investigators at McGill University in Montreal reported that moderate alcohol consumption–defined as six drinks or less per week–by adults is positively associated with an elevated risk of various cancers including stomach cancer, rectal cancer, and bladder cancer.

And now for the study you haven’t heard of. Writing in the August issue of the journal Cancer Prevention Research, investigators from Rhode Island’s Brown University along with researchers at Boston University, Louisiana State University, and the University of Minnesota reported that that lifetime marijuana use is associated with a “significantly reduced risk” of head and neck squamous cell carcinoma.

As I’ve written previously, both on this blog and elsewhere, for 35 years the federal government has been well aware –- yet publicly denied –- that cannabis possesses potent anti-cancer and anti-tumor properties. Even under the Obama administration, which promised to “base [their] public policies on the soundest of science,” the myth that pot promotes cancer persists. In fact, the White House’s website, whitehousedrugpolicy.gov, presently warns, “Marijuana has the potential to promote cancer of the lungs and other parts of the respiratory tract.”

Of course, this myth persists in large part because the mainstream media rarely if ever pays attention to studies that could be seen as in any way undermining criminal prohibition. (In some cases, the MSM even goes so far as to erroneously report about those that do.) So it’s hardly surprising that in the three week span since the Brown University study was published, not one mainstream media outlet has reported its findings. (Full disclosure: over the past days I have personally communicated with several prominent newspapers’ writers about this study — in each case providing them with the full text of the investigators’ findings — but have yet to received any positive feedback beyond the obligatory “We’ll look into it.”)

Will the promotion of these findings in prominent alt-media outlets like The Hill and Huff Po reverse the MSM’s complacency? Perhaps — and your feedback to both sites can only help. So chime in (**Note: comments on both sites are moderated), and tell the MSM that it’s time for us to stop having to do their job!

Unless you want to address marijuana’s illegality and the lives that are shattered by the effects of marijuana prohibition. In that case, the corporate media cannot have anything to do with you, even if you want to pay to broadcast the message of ending adult marijuana prohibition.

Case in point: CBS. At the end of June, CBS’s new internet radio venture, ChatAboutIt.com, contacted NORML. One of our advisory board, Ann Druyan, advertised her podcast in Talkers Magazine, an industry journal for talk radio. ChatAboutIt was interested in hosting Druyan’s show, but Druyan wasn’t interested in the offer.

This is where I come in. I am a talk radio professional, having hosted my show (The Russ Belville Show) on XM Satellite Radio and AM 620 KPOJ in Portland, for almost two years. I have guest-hosted for the extremely popular Bill Press Show in Washington DC. For the past year and a half, I have hosted NORML’s Daily Audio Stash, the organization’s daily news and interviews podcast. I contacted ChatAboutIt to discuss creating a new live talk radio show dedicated to this incredibly popular phenomenon around medical marijuana and marijuana legalization called NORML SHOW LIVE.

Throughout the negotiations, the salesman from ChatAboutIt was fantastic. He joined me and NORML’s executive staff by conference call. We emphasized that we are NORML, the National Organization for the Reform of Marijuana Laws. We told them that we would have advertisers involved with promoting marijuana - legally, as they are co-ops and dispensaries in California and Colorado – marijuana-themed magazines, doctors, clinics, authors, musicians, and so on. We told them we would be talking about marijuana legalization, our web page would have marijuana leaves on it, callers would be talking about marijuana, and, oh, by the way, did we mention that the show was about marijuana?

It’s all good, we were assured by the salesman. He said he’d run it all by his VP and this was fine. He said we’d own all our content and we could run all our ads. We verbally agreed this was a go and all we needed to do was to raise the $6,000 necessary to pay for the first two months of broadcast. We explained that we’d need to produce some press releases to raise the money. To be sure we weren’t saying or promoting anything in any way that CBS would not approve, we submitted our release to CBS, which did make some changes. They approved of our revised release and we posted it on the NORML Blog and front page on Wednesday.

Thursday morning I receive a call from the salesman at ChatAboutIt. “People higher up” had seen the release “on the blogs” and they “will not green light your show”.

Now, CBS has all the right in the world to decide what to put on their airwaves or cyberstreams; I’m not crying “censorship”. If they want to pass up affiliation with the most recognized brand in marijuana and a professional live call-in show dealing with the hottest topic in the media, that’s their call.

What I am crying, though, is “hypocrisy”.

CBS's Showtime is airing the fifth season of "Weeds"

See, CBS owns Showtime. That very same Showtime that’s aired for the past five years the tale of Nancy Botwin, suburban pot-dealing mom on Weeds. A show that films many scenes in the legal marijuana clinics and dispensaries in California that would be our advertisers. A show that just this year signed contracts with NORML to allow display of our trademark in the scenes where it is shown in Weeds.

And it cannot be that CBS is OK with airing a dramatic interpretation of marijuana culture, but afraid of airing a serious news program about marijuana culture. CBS News has an entire web special feature entitled “Marijuana Nation” (not-so-coincidentally the tag line of NORML SHOW LIVE) devoted to all their news coverage about marijuana dating back to Mike Wallace in 1968.

CBS will show Weeds to make money off of people who like marijuana, but won’t allow its banner advertisements for Weeds to be seen on any website trying to keep those marijuana lovers from arrest and a criminal record. CBS will pepper their news coverage and websites with cannaporn* and cannabusiness, but won’t allow a non-profit organization attempting to legalize those industries to have a voice on their networks.

Case #2: In addition to hosting NORML’s podcast and social blog, I am NORML’s Outreach Coordinator. In this position I recruit activists from all across the country (even the US Virgin Islands) to organize NORML chapters. These independent affiliates host events, gather petition signatures, and provide education to the community to counteract the anti-marijuana propaganda from the government (such as our “drug czar” recently proclaiming – in California, no less – that “Marijuana is dangerous and has no medicinal benefit.”)

I was contacted by the tour manager for the “Blazed and Confused” Tour. The artists performing in the most pro-marijuana concert of the summer are Mickey Avalon, Bob Marley’s son Stephen Marley, San Diego rockers Slightly Stoopid, and Snoop Dogg, probably the most recognizable person alive associated with marijuana aside from Willie Nelson. They, particularly Slightly Stoopid, wanted NORML chapters to host marijuana information tables for the concerts and offered us the opportunity for free.

Pot leaf skull at Blazed & Confused tour at NBC Universal's Hard Rock this Saturday

I combed through my chapter listings and got them NORML booths for over half the shows. At the show in Portland I got to interview Miles from Slightly Stoopid and wander around backstage. The props for the Stoopid show were two massive five foot skulls with pot leaves on the forehead. Snoop’s show featured a huge backdrop reading “Tales from the Crip” and marijuana leaves were all around. Everyone performing at or attending this concert was very pro-marijuana legalization.

Yet this morning I’m contacted by the tour people who tell me they need to cancel the booth we have scheduled for the show last Saturday in Orlando. It seems the venue is the Hard Rock, and “because they are a Universal owned company they are much more conservative than your typical venue.”

Available from NBC Universal

This Universal, of course, is NBC Universal, the parent company to the MSNBC and CNBC networks that reported their highest ratings ever for their marijuana-themed news reports on the burgeoning cannabis business in California. The same NBC Universal that is happy to sell you Cheech & Chong’s Next Movie, Dazed & Confused, and Half Baked on DVD. The same NBC Universal that has no problem allowing Snoop Dogg to get the crowd at the Hard Rock in Orlando to chant “Legalize It”, but somehow can’t let a couple of college kids in NORML T-shirts hand out educational fliers about why we should legalize it.

Case #3: Another marijuana legalization organization, Marijuana Policy Project (MPP), produced an excellent TV ad calling for passage of a bill to tax and regulate cannabis for adults. The governor had recently called for an open debate about legalization and MPP created this thirty second ad to begin that debate:

Click here to view the embedded video.

Certainly a sober and non-sensational way to debate the issue. Yet when MPP offered the ad to California stations, Los Angeles’ KABC (ABC) and KTTV (FOX), San Francisco’s KGO (ABC), and San Jose’s KNTV (NBC) refused to accept the ad. KNTV said their standards department wouldn’t approve the ad. KGO issued an official “no comment.” KABC and KTTV didn’t even bother give the courtesy of a “no comment” – they would not respond to MPP’s inquiries.

I’ve detailed NBC’s and CBS’s profiting from cannabis culture. You’d think ABC, being a part of the Walt Disney Corporation, would generally shy away from profiting from cannabis culture. But a little digging shows they own Miramax films, which this year released Adventureland, a comedy about teenagers smoking and dealing weed while working at an amusement park and in 2001 offered Jay & Silent Bob Strike Back, the adventures of two inveterate stoners who wrote a stoner comic book. FOX for eight years aired That 70′s Show, a ratings hit whose signature sight gag was teenagers sitting in a smoke-filled basement passing around a joint or bong (never seen, however), with the camera focusing on each character as they “passed the dutchie on the left hand side”.

So it is OK for the corporate parents of CBS, NBC, ABC, and FOX to profit from movies and TV shows that satirize marijuana culture, but they have a “standards and practices” problem with their broadcast affiliates showing 30 seconds of a 38-year-old woman suggesting we should tax and regulate marijuana.

Keep in mind in these cases, we are talking about one part of the big media company raking in huge profits with shows about the marijuana community, while another part of the big media company refuses the free educational fliers, paid advertisements, and pay-to-play broadcasts BY AND FOR the marijuana community. Marijuana is the modern day minstrel show – we’re allowed on the air as long as we keep on our “greenface”, shuck and jive (or would it be “smoke and pass”?), and never forget our proper place.

By the way, the NORML SHOW LIVE mentioned in Case #1 will still be going on the air, as promised, on Labor Day Weekend. Unlike CBS, we keep our promises to our customers. The money raised will go into promotions and producing our show through the facilities of BlogTalkRadio.com, which was happy to accept our business, and quite frankly, offers us a better production technology at one-sixth the price. Tune in every Saturday Night at 9pm Eastern for two hours of intelligent discussion about marijuana legalization.

* Cannaporn is the news specials that like to show lots and lots of pictures of big green sticky buds and the people smoking them, usually the same stock footage they’ve run for years with the most stereotypical “stoner” types they can find, lots of pictures of bongs and tie dyes, some b-roll from a music festival, or body-armored police helicoptering in to chop down marijuana plants, while intoning the reefer madness du jour about increased potency, psychosis, or clandestine cartel grows and violence that wouldn’t exist in a legal market. In other words, not what you will find on NORML SHOW LIVE.

Writing Wrongs
via The Philadelphia Weekly

Bad journalism is to blame for marijuana prohibition. … The truth is, most people who use drugs — both legal and illegal — do so responsibly and without any noticeable detrimental effect. [Yet,] since the 1980s, drug policy — with the help of the press — has demonized drug users.

… Scientific studies are frequently reported in the media without the reporter having read more than a press release, and without any regard to sample size.

… In other cases, the news media ignore important drug–related stories — such as the federal government listing cannabis as Schedule I, alongside heroin and LSD; or that the past two presidential administrations have arrested patients authorized by states to use medical marijuana.

… It’s sad how long people have been pointing out this bad journalism, and how little anything seems to change.  

Back in March I wrote an essay for Alternet.org dissecting how the mainstream media falsely reported that inhaling cannabis poses a greater cancer risk than smoking tobacco — based on a study that concluded the opposite result. More recently, I lectured on this topic before attendees at the Fifth National Clinical Conference on Cannabis Therapeutics. It’s a subject worth revisiting.

So why does the media consistently ‘get the story wrong’ when it comes to pot? While I don’t believe there’s any grand conspiracy going on, I do believe that journalists in general engage in several bad habits that negatively skew their cannabis coverage.

First, beat writers too often base their pot-related health and science stories on press releases rather than actual data.

Second, the mainstream media often chooses to selectively highlight data implicating cannabis’s dangers while ignoring data implicating its relative safety.

Third, and perhaps most importantly, mainstream news stories about pot seldom make references to previously published research (research that typically disproves the crux of the media’s latest scare story) or place new data in context.

Writing in the journal Science nearly 40 years ago, New York state university sociologist Erich Goode aptly observed: “[T]ests and experiments purporting to demonstrate the ravages of marijuana consumption receive enormous attention from the media, and their findings become accepted as fact by the public. But when careful refutations of such research are published, or when latter findings contradict the original pathological findings, they tend to be ignored or dismissed.”

How little has changed.